Nivolumab: Does the Extended CheckMate-274 Results Prove It’s the Ultimate for MIBC? ASCO GU 2025 ASCO GU 3 Mins Read Extended CheckMate-274 Results Show Continued Benefit With Nivolumab in MIBCDate: February 14, 2025Author: Dr. Matthew I. Milowsky, MD, FASCO, University…
Urothelial Cancers Phase 3 Trial KEYNOTE-045 and KEYNOTE-361 Efficacy and Safety Results Bladder 3 Mins Read Patrizia Giannatempo, MD, from the Fondazione IRCCS Istituto Nazionale dei Tumori, has conducted extensive research on the impact of histology…
Urothelial Carcinoma PROOF 302: A phase III trial of Infigratinib in FGFR3 alterations Bladder 3 Mins Read Petros Grivas, MD, PhD, an expert in urothelial carcinoma (UC) research at the University of Washington, has made significant contributions…
